Clinical trials
Urinary Bladder, Overactive trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Inc | 8 |
| Allergan | 5 |
| Astellas Pharma Europe B.V. | 5 |
| Pfizer | 5 |
| Astellas Pharma Europe Ltd. | 3 |
| Bayer | 2 |
| Ipsen | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Institute of Health Information and Statistics of the Czech Republic | 1 |
| Ono Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder, Overactive | 37 |
| Urinary Incontinence | 15 |
| Urinary Incontinence, Urge | 5 |
| Urinary Bladder Diseases | 4 |
| Urologic Diseases | 4 |
| Nocturia | 2 |
| Lower Urinary Tract Symptoms | 1 |
| Prostatic Hyperplasia | 1 |
| Signs and Symptoms | 1 |
| Urological Manifestations | 1 |
Trials
Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.